Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.

The efficacy of oral WIN 54954 for the prevention of rhinovirus infection and illness was tested in two randomized, double-blinded, placebo-controlled volunteer challenge studies. Volunteers were inoculated with rhinovirus type 39 (MIC of WIN 54954, 0.17 microgram/ml) or rhinovirus type 23 (MIC, 0.0...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Turner, R B, Dutko, F J, Goldstein, N H, Lockwood, G, Hayden, F G
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187656/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8383943/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.2.297
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!